AdvanCell

AdvanCell is a radiopharmaceutical company developing next-generation cancer treatments. AdvanCell's targeted alpha therapy is supported by platform technology – the world’s first alpha isotope generator, addressing the largest unmet need in targeted alpha therapy with a reliable and scalable isotope supply. AdvanCell boasts a world-class team and is honored to receive guidance from an outstanding board of directors and scientific advisory board.